High efficiency myogenic conversion of human fibroblasts by adenoviral vector-mediated MyoD gene transfer. An alternative strategy for ex vivo gene therapy of primary myopathies.

Ex vivo gene therapy of primary myopathies, based on autologous transplantation of genetically modified myogenic cells, is seriously limited by the number of primary myogenic cells that can be isolated, expanded, transduced, and reimplanted into the patient's muscles. We explored the possibility of using the MyoD gene to induce myogenic conversion of nonmuscle, primary cells in a quantitatively relevant fashion. Primary human and murine fibroblasts from skin, muscle, or bone marrow were infected by an E1-deleted adenoviral vector carrying a retroviral long terminal repeat-promoted MyoD cDNA. Expression of MyoD caused irreversible withdrawal from the cell cycle and myogenic differentiation in the majority (from 60 to 90%) of cultured fibroblasts, as defined by activation of muscle-specific genes, fusion into contractile myotubes, and appearance of ultrastructurally normal sarcomagenesis in culture. 24 h after adenoviral exposure, MyoD-converted cultures were injected into regenerating muscle of immunodeficient (severe combined immunodeficiency/beige) mice, where they gave rise to beta-galactosidase positive, centrally nucleated fibers expressing human myosin heavy chains. Fibers originating from converted fibroblasts were indistinguishable from those obtained by injection of control cultures of lacZ-transduced satellite cells. MyoD-converted murine fibroblasts participated to muscle regeneration also in immunocompetent, syngeneic mice. Although antibodies from these mice bound to adenoviral infected cells in vitro, no inflammatory infiltrate was present in the graft site throughout the 3-wk study period. These data support the feasibility of an alternative approach to gene therapy of primary myopathies, based on implantation of large numbers of genetically modified primary fibroblasts massively converted to myogenesis by adenoviral delivery of MyoD ex vivo.

[1]  E. Thompson,et al.  A quantitative technique for growing human adult skeletal muscle in culture starting from mononucleated cells , 1977, Journal of the Neurological Sciences.

[2]  D. Fischman,et al.  Immunochemical analysis of myosin heavy chain during avian myogenesis in vivo and in vitro , 1982, The Journal of cell biology.

[3]  E. Schultz,et al.  Skeletal muscle satellite cells: Changes in proliferation potential as a function of age , 1982, Mechanisms of Ageing and Development.

[4]  J. Sambrook,et al.  Molecular Cloning: A Laboratory Manual , 2001 .

[5]  S. Heinemann,et al.  Isolation of a clone coding for the alpha-subunit of a mouse acetylcholine receptor , 1985, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[6]  H. Weintraub,et al.  Expression of a single transfected cDNA converts fibroblasts to myoblasts , 1987, Cell.

[7]  P. Chomczyński,et al.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.

[8]  J. Aubin,et al.  Differentiation of muscle, fat, cartilage, and bone from progenitor cells present in a bone-derived clonal cell population: effect of dexamethasone , 1988, The Journal of cell biology.

[9]  H. Blau,et al.  Accelerated age-related decline in replicative life-span of Duchenne muscular dystrophy myoblasts: Implications for cell and gene therapy , 1990, Somatic cell and molecular genetics.

[10]  H. Weintraub,et al.  MyoD induces growth arrest independent of differentiation in normal and transformed cells. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[11]  Robert K. Davis,et al.  The myoD gene family: nodal point during specification of the muscle cell lineage. , 1991, Science.

[12]  T. Braun,et al.  The muscle regulatory gene, Myf-6, has a biphasic pattern of expression during early mouse development , 1991, The Journal of cell biology.

[13]  G. Lyons,et al.  Developmental regulation of creatine kinase gene expression by myogenic factors in embryonic mouse and chick skeletal muscle. , 1991, Development.

[14]  T. Furlong.  Myoblast transplantation. , 1992, Science.

[15]  P. Tonali,et al.  Retroviral vector-mediated gene transfer into human primary myogenic cells leads to expression in muscle fibers in vivo. , 1993, Human gene therapy.

[16]  William H. Klein,et al.  Muscle deficiency and neonatal death in mice with a targeted mutation in the myogenin gene , 1993, Nature.

[17]  G. Cossu,et al.  A population of myogenic cells derived from the mouse neural tube , 1994, Neuron.

[18]  G. Butler-Browne,et al.  Clones of human satellite cells can express in vitro both fast and slow myosin heavy chains. , 1994, Developmental biology.

[19]  J. Tremblay,et al.  High efficiency of muscle regeneration after human myoblast clone transplantation in SCID mice. , 1994, The Journal of clinical investigation.

[20]  S. Ferrari,et al.  Differential response of embryonic and fetal myoblasts to TGF beta: a possible regulatory mechanism of skeletal muscle histogenesis. , 1994, Development.

[21]  E. Hoffman,et al.  Genetic and biochemical normalization in female carriers of Duchenne muscular dystrophy , 1995, Neurology.

[22]  D. Watt,et al.  Dermal fibroblasts convert to a myogenic lineage in mdx mouse muscle. , 1995, Journal of cell science.

[23]  A J Harris,et al.  Myogenic conversion of mammalian fibroblasts induced by differentiating muscle cells. , 1995, Journal of cell science.

[24]  F. Rieger,et al.  Myotube driven myogenic recruitment of cells during in vitro myogenesis , 1995, Developmental dynamics : an official publication of the American Association of Anatomists.

[25]  G. Cossu,et al.  Myosin light chain 3F regulatory sequences confer regionalized cardiac and skeletal muscle expression in transgenic mice , 1995, The Journal of cell biology.

[26]  M. O'hare,et al.  Establishment of long-term myogenic cultures from patients with Duchenne muscular dystrophy by retroviral transduction of a temperature-sensitive SV40 large T antigen. , 1996, Experimental cell research.

[27]  G. Butler-Browne,et al.  SV40 large T antigen interferes with adult myosin heavy chain expression, but not with differentiation of human satellite cells. , 1996, Experimental cell research.

[28]  J. Wilson,et al.  Immunology of gene therapy with adenoviral vectors in mouse skeletal muscle. , 1996, Human molecular genetics.

[29]  S M Schwartz,et al.  Muscle differentiation during repair of myocardial necrosis in rats via gene transfer with MyoD. , 1996, The Journal of clinical investigation.

[30]  R. Balice-Gordon,et al.  In vivo expression of full-length human dystrophin from adenoviral vectors deleted of all viral genes. , 1996, Human gene therapy.

[31]  C. Gravel,et al.  Myoblast Transplantation in Monkeys: Control of Immune Response by FK506 , 1996, Journal of neuropathology and experimental neurology.

[32]  S. Kochanek,et al.  Persistence in muscle of an adenoviral vector that lacks all viral genes. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[33]  G. Cossu.  Unorthodox myogenesis: possible developmental significance and implications for tissue histogenesis and regeneration. , 1997, Histology and histopathology.

[34]  C. Huard,et al.  Prevention by anti-LFA-1 of acute myoblast death following transplantation. , 1997, Journal of immunology.

[35]  M. Levrero,et al.  A temperature-conditional mutant of simian virus 40 large T antigen requires serum to inhibit myogenesis and does not induce DNA synthesis in myotubes. , 1997, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.